Zana Technologies GmbH
Zana is a deep tech healthcare company based in Germany, leveraging AI and voice technology to develop patient-centric solutions. Their platform focuses on voice biomarkers for health analysis, enabling proactive care and remote monitoring. With applications in cardiology and respiratory diseases, Zana aims to improve patient outcomes and reduce hospitalization costs. Since its founding in 2018, Zana has established partnerships with pharmaceutical and MedTech companies, enhancing clinical trials and patient monitoring through innovative voice analysis.
Zana Technologies GmbH
Zana is a deep tech healthcare company based in Germany, leveraging AI and voice technology to develop patient-centric solutions. Their platform focuses on voice biomarkers for health analysis, enabling proactive care and remote monitoring. With applications in cardiology and respiratory diseases, Zana aims to improve patient outcomes and reduce hospitalization costs. Since its founding in 2018, Zana has established partnerships with pharmaceutical and MedTech companies, enhancing clinical trials and patient monitoring through innovative voice analysis.
TL;DR
Founded: 2018 in Germany
What they do: Deep-tech digital health company using conversational/voice AI and wearables integration to deliver patient companion apps and remote monitoring
Regulatory status: CE-marked medical device (platform, noted 2020)
R&D focus: Vocal biomarkers for heart failure and respiratory diseases (asthma/COPD)
Funding & investors: Seed-stage fundraising with Plug and Play Insurtech listed as lead and EXIST as backer; total funding shown as $460,000 (USD) in available snapshot
Dr.-Ing. Julia Hoxha (Co‑Founder & CEO) and Armand Brahaj (Co‑Founder & CTO)
Company Overview
Problem Domain
Remote patient monitoring and digital patient engagement with focus on vocal biomarkers for heart failure and respiratory diseases (asthma/COPD).
Founded
2018
Industry
Digital health / Healthtech
Tech Stack
Funding Track Record
Dealroom lists a funding table entry in June 2019 (amount not disclosed in accessible view).
EIT Health Investor Network supported/facilitated the company's Seed‑round fundraising in 2022; EXIST listed as a grant/backer.
Dealroom shows an entry for an EIT Health support program in January 2024 (amount not disclosed in accessible view).
Investor Signal
“Seed‑stage investor support includes Plug and Play Insurtech as lead and EXIST as a grant/backer; supported by EIT Health Investor Network for Seed fundraising.”